Skip to content
HomeLatest newsJohnson & Johnson Wants to Tap Innovators Worldwide to Help Create the Healthiest Generation
gen H Challenge Alex Lede

Johnson & Johnson Wants to Tap Innovators Worldwide to Help Create the Healthiest Generation

Through the GenH Challenge, the company is inviting big thinkers and entrepreneurs to help change the global trajectory of healthcare.

Share Article
share to

At Johnson & Johnson, we know and value that great innovation is at the heart of good healthcare—and that breakthrough ideas can come from anyone, anywhere.

That’s why we’re launching the GenH Challenge, a global social venture competition dedicated to finding solutions for some of the world’s toughest health problems, so we can help create the healthiest generation ever.
Because people are the key to great ideas, we’re inviting innovators and social entrepreneurs worldwide to design new approaches to ignite progress in five areas of Johnson & Johnson’s commitment to the United Nations Sustainable Development Goals: Women & Children, Essential Surgery, Environment, Healthy Workforce and Global Disease Challenges.

And we are committing $1 million in cash and other incentives to help six winners bring their big ideas to life.

Learn more details about how you can get involved in this exciting opportunity from Alex Gorsky, Johnson & Johnson’s Chairman and CEO, in the video below.

Put simply: By pairing your ingenuity with our experience, we can make great strides together.

1775614113001-5356788324001-5353351657001-vs.jpg
17-029 AG genH EXTERNAL v3_H264

Have a Great Idea to Submit to the GenH Challenge?

Find out how to sign up—and easily share the details with enterprising friends.

More from Johnson & Johnson

Giving the gift of sight

In Kenya, around 1.5 million people—including children—contend with visual impairment or blindness. Sight For Kids, Johnson & Johnson’s global eye-care partnership, is devoted to changing these stats, one vision screening at a time.

Inside the development of a revolutionary treatment for blood cancers

In 2014, a Johnson & Johnson therapy gained approval for the treatment of a type of B-cell malignancy—increasing survival rates and changing the way scientists approach cancer treatment. These 8 milestone moments tell the transformational story.

“Lung cancer wasn’t even on my radar. Then I was diagnosed.”

The disease is often detected late—which can have fatal consequences. But thanks to innovations in diagnostic tools, there’s a way to catch lung cancer earlier. Here’s how early detection saved one woman’s life.
You are now leaving jnj.com. The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.